FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
FDA General

Stop Inaccurate Health Info: HHS Staff to RFK, Jr.

Some 750 current and former HHSers call on secretary Robert F. Kennedy, Jr., to protect them and the rest of his staff from attacks by ending his inac...

Medical Devices

FDA Updates Breakthrough Device Statistics

Updated medical device breakthrough device designation metrics show 1,176 approvals since 2015 and 160 marketing authorizations.

latest-news-card-1
Medical Devices

FDA DrugSorb-ATR Options

FDA suggests ways CytoSorbents can proceed with its de novo application for DrugSorb-ATR.

latest-news-card-1
Human Drugs

Act Against Compounded Semaglutide: Petition

Wiley Rein petitions FDA to take seven specific actions to address public health risks associated with compounded semaglutide drug products.

latest-news-card-1
Biologics

2 Eylea HD Submissions Get Review Extensions

FDA extends until the fourth quarter the review of two Regeneron Pharmaceuticals regulatory submissions for Eylea HD (aflibercept) injection 8 mg regu...

latest-news-card-1
Human Drugs

B. Braun Recalls 2 Drugs Over Particulate Matter

B. Braun Medical recalls (Class 1) one lot each of its Lactated Ringers Injection USP 1,000 mL and 0.9% sodium chloride injection USP 1,000 mL due to...

latest-news-card-1
Medical Devices

Multiple Les Encres Violations

FDA warns Lenoir City, TN-based Les Encres LLC about QS and MDR violations in its illegal work as a specification developer for adulterated and misbra...

latest-news-card-1
Human Drugs

Alcohol Use Disorder Drug Gets Fast Track

FDA grants Altimmune a fast track designation for pemvidutide and its use for treating alcohol use disorder.

latest-news-card-1
Human Drugs

CGMP Violations Seen in Anhui Hanbon Inspection

FDA warns Chinas Anhui Hanbon Daily Chemical Co. about CGMP violations in its production of finished drugs.

latest-news-card-1
FDA General

FDA Pushes Back Review of Hunter Syndrome BLA

FDA extends by 90 days its review of a Regenxbios BLA for RGX-121 (clemidsogene lanparvovec), an investigational gene therapy for Hunter syndrome.